• Growth drivers: Consumer growth reached 15.4% driven by urban demand recovery, tax and budget relief, market share gains, double-digit growth in Fevicol, and strong performance in Roff and Dr. Fixit.
• Margin guidance: Operating leverage expanded EBITDA margins to 23.2%, and management maintained an annual EBITDA margin corridor guidance of 20% to 24% amid cost inflation linked to the West Asia crisis.
• B2B segment growth: Underlying B2B volume growth stood at approximately 14.8% on the back of strong domestic projects and industrial demand, offsetting export headwinds.
• Pricing actions: In response to weighted average raw material inflation of 40% to 50%, the company implemented calibrated price increases totaling roughly 12% to 15% across April and May to pass on absolute cost increases.